| |
|
| |
|
|
|
Irish Medical Devices Association (IMDA) publishes Yearbook 2010 Feb 2011 IMDA published at the end of last year its Yearbook 2010 providing an in-depth review of the positive progress made by the association on its 2010 priorities. The Yearbook also details how the association has been collaborating with Government departments, development agencies, the clinical community and regulators.. Ireland is now the second largest exporter of medical products in Europe, only behind Germany, with exports climbing by over nine per cent in 2009. |
|||
EU Report maps high transnational participation of European countries in R&D collaboration in the framework of ERA-NET 27 Jan 2011 The “Joint Research Center (JRC) Institute The “Joint Research Center (JRC) Institute for Prospective Technological Studies” recently published a report that finds that all European countries are highly involved in the ERA-NET scheme. The report “Mapping ERA-NETs across Europe: overview of the ERA-NET scheme and its results” reveals a 28% increase in participation as compared to 2008, with France and Germany identified as leading participants The report also highlights the most relevant thematic priorities as well as the main groups taking part in the scheme. The report was produced in the framework of NETWATCH - the European Commission’s information platform on transnational R&D programme collaboration.
1- Related JRC press release |
|||
Report: Generics will continue domination on the pharmaceutical market in Europe until 2011 Source: Report from PMR (http://www.ceepharma.com/) The pharmaceutical market in Central and Eastern Europe is dominated by generic drugs. This subdivision was worth €17.2bn in 2008 and is expected to develop by around 14% per annum between 2009 and 2011. The growth rate of the innovative drug market, which was worth €12.4bn in 2008, will be slower, according to the latest report from PMR, a research and consulting company, entitled “Generic and innovative drugs market in Central and Eastern Europe 2009. Comparative analysis, reimbursement policies and development forecasts for 2009-2011”. Generics to account for 60% of the market in 2009 The CAGR for generics will reach as much as 14% between 2009 and 2011, whereas that of innovative drugs will be much lower. “As a result, the share of generic drugs will constantly increase and in 2009 generics will account for around 60% of the pharmaceutical market in Central and Eastern Europe”, according to Agnieszka Stawarska, Pharmaceutical Market Analyst at PMR and a co-author of the report. Although the innovative drug market in Central and Eastern Europe will develop at a slower rate than that of generic drugs between 2009 and 2011, the growth rate of original medicines for the whole region will be positive. It has, for the time being, been compromised by the cost-containment policies of the CEE countries, which have been stepped up during the global financial crisis. However, in the medium term PMR expects an improvement in health awareness and the modernisation of healthcare systems, including the development of private health insurance and the establishment of health insurance and drug reimbursement systems, similar to those in European countries, in Russia and Ukraine, to be drivers of the innovative drug market in the CEE countries. An additional driver will be the aging of the population in the region. Local companies are generic-oriented The second group of companies consists of “global generic players”. Their presence differs from one CEE country to the next. For example, Dr. Reddy’s, an Indian generic manufacturer, concentrates on Russia, which is one of the company’s key markets worldwide. Actavis, an Iceland-based manufacturer, is at its strongest in Bulgaria and Russia. Ranbaxy’s key markets in the region are Romania and the CIS countries (Russia and Ukraine in particular). Stada has a strong presence in Russia, particularly after the acquisition of two Russian companies (Nizhpharm and Makiz-Pharma); and at the beginning of 2009 the company entered Poland and Bulgaria by establishing subsidiaries there. In June 2008, Mylan, a US generic manufacturer, acquired the CEE generics businesses of Merck KGaA, the prominent German drug manufacturer. The deal includes Merck’s operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic. In March 2009 Zentiva, one of the leading generic players in the region, was bought by Sanofi-Aventis. In May 2009 Novartis acquired the generic cancer drug production division of the Austria-based EBEWE Pharma. …whereas innovation is the domain of global concerns Other PMR-PHARMA related Articles: December 2009: The Polish Pharmaceutical Market. Its Condition and Prospects for Growth until 2011 PMR (www.pmrcorporate.com) is a publishing, consulting and market research company providing information, advice and services to international businesses interested in Central and Eastern Europe. With highly skilled staff, top ranked web sites and more than ten years of experience, PMR is one of the largest companies of its type in the region. |
|||
“COACH”: CANADA'S HEALTH INFORMATICS ASSOCIATION Source: http://www.coachorg.com COACH is an organization dedicated to promoting a clear understanding of health informatics within the Canadian health system through education, information, networking and communication. A MESSAGE from the PRESIDENTThe COACH Vision: Taking Health Informatics MainstreamThe term vision is often associate to images of the future and anticipation of positive, sometimes remarkable things to come. At COACH, we know our Vision of Taking Health Informatics Mainstream is being realized in very real ways as a growing number of Canadians recognize and understand the important role IT can play in administrative and clinical best practice and ultimately in improving healthcare.
COACH has already started the process of translating these objectives into action. Most recently, for example, actively engaging members took the form of the online Member Survey that will help shape our new Marketing and Communications Plan. The commitment to expanding product and service offerings can be seen in the Executive Forum, launched in 2007, and the new Health Informatics Training System (HITS) online course as well as new developments such as the HIP@Work pilot project to facilitate the use of our Health Informatics Professional Core Competencies document. |
|||
“COACH”: CANADA'S HEALTH INFORMATICS ASSOCIATION Source: http://www.coachorg.com COACH is an organization dedicated to promoting a clear understanding of health informatics within the Canadian health system through education, information, networking and communication. A MESSAGE from the PRESIDENTThe COACH Vision: Taking Health Informatics MainstreamThe term vision is often associate to images of the future and anticipation of positive, sometimes remarkable things to come. At COACH, we know our Vision of Taking Health Informatics Mainstream is being realized in very real ways as a growing number of Canadians recognize and understand the important role IT can play in administrative and clinical best practice and ultimately in improving healthcare.
COACH has already started the process of translating these objectives into action. Most recently, for example, actively engaging members took the form of the online Member Survey that will help shape our new Marketing and Communications Plan. The commitment to expanding product and service offerings can be seen in the Executive Forum, launched in 2007, and the new Health Informatics Training System (HITS) online course as well as new developments such as the HIP@Work pilot project to facilitate the use of our Health Informatics Professional Core Competencies document. |
|||
Report: Generics will continue domination on the pharmaceutical market in Europe until 2011 Source: Report from PMR (http://www.ceepharma.com/) The pharmaceutical market in Central and Eastern Europe is dominated by generic drugs. This subdivision was worth €17.2bn in 2008 and is expected to develop by around 14% per annum between 2009 and 2011. The growth rate of the innovative drug market, which was worth €12.4bn in 2008, will be slower, according to the latest report from PMR, a research and consulting company, entitled “Generic and innovative drugs market in Central and Eastern Europe 2009. Comparative analysis, reimbursement policies and development forecasts for 2009-2011”. Generics to account for 60% of the market in 2009 The CAGR for generics will reach as much as 14% between 2009 and 2011, whereas that of innovative drugs will be much lower. “As a result, the share of generic drugs will constantly increase and in 2009 generics will account for around 60% of the pharmaceutical market in Central and Eastern Europe”, according to Agnieszka Stawarska, Pharmaceutical Market Analyst at PMR and a co-author of the report. Although the innovative drug market in Central and Eastern Europe will develop at a slower rate than that of generic drugs between 2009 and 2011, the growth rate of original medicines for the whole region will be positive. It has, for the time being, been compromised by the cost-containment policies of the CEE countries, which have been stepped up during the global financial crisis. However, in the medium term PMR expects an improvement in health awareness and the modernisation of healthcare systems, including the development of private health insurance and the establishment of health insurance and drug reimbursement systems, similar to those in European countries, in Russia and Ukraine, to be drivers of the innovative drug market in the CEE countries. An additional driver will be the aging of the population in the region. Local companies are generic-oriented The second group of companies consists of “global generic players”. Their presence differs from one CEE country to the next. For example, Dr. Reddy’s, an Indian generic manufacturer, concentrates on Russia, which is one of the company’s key markets worldwide. Actavis, an Iceland-based manufacturer, is at its strongest in Bulgaria and Russia. Ranbaxy’s key markets in the region are Romania and the CIS countries (Russia and Ukraine in particular). Stada has a strong presence in Russia, particularly after the acquisition of two Russian companies (Nizhpharm and Makiz-Pharma); and at the beginning of 2009 the company entered Poland and Bulgaria by establishing subsidiaries there. A number of consolidation processes recently took place in the generic arena, which were of great importance for Central and Eastern Europe. For example, Teva gained a strong presence in the region through the acquisition of Barr in July 2008, which included one of the largest local generic drug producers − the Croatian company Pliva. In June 2008, Mylan, a US generic manufacturer, acquired the CEE generics businesses of Merck KGaA, the prominent German drug manufacturer. The deal includes Merck’s operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic. In March 2009 Zentiva, one of the leading generic players in the region, was bought by Sanofi-Aventis. In May 2009 Novartis acquired the generic cancer drug production division of the Austria-based EBEWE Pharma. …whereas innovation is the domain of global concerns Today innovative companies face a crisis associated with the loss of patent rights pertaining to their most important products, which is expected to affect their sales performance in Central and Eastern Europe also, as many players of domestic origin may launch the generic equivalents of their drugs on the market. Other PMR-PHARMA related Articles: December 2009: The Polish Pharmaceutical Market. Its Condition and Prospects for Growth until 2011 PMR (www.pmrcorporate.com) is a publishing, consulting and market research company providing information, advice and services to international businesses interested in Central and Eastern Europe. With highly skilled staff, top ranked web sites and more than ten years of experience, PMR is one of the largest companies of its type in the region. |
|||
Report: Europe Offers Guidance for Health IT Expansion in U.S. Source: iHealthBeat (ihealthbeat.org) 03 Aug 2009 Although U.S. health IT expansion efforts are following many best practices from Europe, several challenges remain for creating a centralized system, according to a new report from the consultancy firm CSC, BNET Healthcarereports. For the report, investigators compared health IT adoption efforts in the U.S. with the experiences of Denmark, the Netherlands and the U.K. The report suggests that U.S. health IT efforts are replicating success from the three European countries by:
Investigators also noted that the establishment of the Health IT Policy and Health IT Standards committees demonstrates that the U.S. recognizes the importance of national criteria and regulations for health IT. However, the authors also identified several ways in which the U.S. could face difficulty in following Europe's lead for health IT adoption, most notably the U.S.'s mixed public and private system that could hinder nationwide health IT adoption. The U.S. also is unlikely to copy Europe in using universal patient identification numbers because of privacy and security concerns, the report noted. Finally, few U.S. physicians use EHRs compared with physicians in the three European countries. Therefore, the U.S. could encounter greater difficulty in achieving nationwide EHR implementation (Terry, BNET Healthcare, 7/31 |
|||
Canada “Health Infoway” Annual Reports and Business Plans25 Jun 2009 Funded by the federal government, Health Infoway works with all provinces and territories to implement private and secure health information systems, and shares or replicates best practices and successful projects among regions Created in 2001, Canada Health Infoway is an independent, not-for-profit organization whose Members are Canada’s 14 Deputy Ministers of Health Learn more aboutEHRs are changing livesIf you are working
|
|||
The Economist Special Report on Health Care Technology17 Apr 2009
|
|||
The Economist Special Report on Health Care Technology17 Apr 2009
|
|||
Safety-Net Providers Bring Patients Online: Lessons from Early AdoptersSource: Califórnia Healthcare Foundation (http://www.chcf.org/) Reports & Initiatives Safety-net providers such as public hospitals, community health centers, and local health departments are starting to provide online tools including electronic health record (EHR) portals and personal health records (PHRs) to their patients.
Programs that provide online tools to migrant workers and homeless people are also described. The lessons gleaned from early adopters focus on understanding patients' needs and capacities; making tools useful; providing training and assistance; recognizing privacy concerns; overcoming organizational barriers; demonstrating impact; and facilitating collaboration with other safety-net providers. Document Downloads: Safety-Net Providers Bring Patients Online: Lessons from Early Adopters (623K) |
|||
Under the Microscope: Trends in Laboratory MedicineSource: Califórnia Healthcare Foundation (http://www.chcf.org/) (The Lewin Group) Laboratory medicine, which plays an integral role in health care, is handicapped by overuse, underuse, and misuse of services; poor communication and coordination; and inefficiency. Labs can generate valuable data to help correct these problems by virtue of numerous scientific and technological breakthroughs that enable early detection of disease and better management of medical conditions.
Laboratory medicine will play an ever greater role in repairing the fractured health care system as stakeholders increasingly demand scientific evidence for clinical decision-making and strategies to address care quality, outcomes, and cost. Document Downloads: Under the Microscope: Trends in Laboratory Medicine (885K) |
|||
Which Online Resources Do Online Health Care Specialists Use?Source: iHealthBeat (a service from Califórnia Healthcare Foundation) www.ihealthbeat.org
|
|||
Australia Review Report on ICT use by e-GOV/2008Source: Australia Government/ Information Management Office In April 2008 Minister for Finance and Deregulation, Lindsay Tanner, engaged Sir Peter Gershon to lead an independent review of the Australian Download : Review of the Australian Government's Use of Information and Communication Technology PDF version [2.6MB] Letter from Sir Peter Gershon to the Hon. Lindsay TannerThe Hon. Lindsay Tanner |
|||
NHS: Health Informatics Review Report16 Jul 2008 This review has been taking place alongside the NHS Next Stage Review (NSR) and reflects the informatics requirements of that review. Groups of staff, patients, carers and the public have been looking at clinical pathways and new ways of providing care. There are needs to support access and choice, the involvement of patients and the public and to meet increasing expectations. These make this the appropriate time for a review of information requirements and how information is provided. The review is also timely because of the technological advances and the rise of the importance of information to society in general. The Health Informatics Review was therefore commissioned by the NHS Chief Executive and the Department of Health Permanent Secretary to:
Download Health Informatics Review Report (.pdf, 717 KB). For further information, please visit: |
|||
Real Stories of Real Results from Real PhysiciansSource: HealthData Mangement (www.healthdatamanagement.com ) Download Now (Report Format: PDF) The increasing demands that the healthcare industry places on its physicians is driving change. The pressures to increase efficiency and grow revenue while at the same time maintaining patient satisfaction has many physicians turning to innovative solutions that promote success. This whitepaper discusses the role of patient-provider communication solutions in helping physician practices manage the complexities of the industry and achieve their most elusive goals. Read about how three unique practices have implemented these solutions for success. |
|||
The HIMSS Analytics Guide to Evaluating Mobile Cart TechnologySource: HealthData Mangement (www.healthdatamanagement.com ) Download Now (Report Format: PDF) This is the essential new guide from HIMSS Analytics for navigating the many mobile cart and workstation options available today. Includes a definitive 25-point checklist of the most critical areas to evaluate , in order to make sure your cart investment integrates with your organization's needs. |
|||
Requirements and options for actions in RFID in healthcare
|
|||
REPORT: Putting eHealth in its European Legal ContextIn: eHealthNes.eu The 1960s and 1970s saw the development of computing technology for mathematical modeling applied to the healthcare setting, along with highly specialized, tailor-made programmes for complex medical models. The early 1990s saw the beginnings of the IT revolution, which took us from the back roads to the super highway. With the development of Internet technology, eHealth became a potential reality not only for healthcare practitioners but for every citizen. It was, however, not until the late 1990s that layers and administrators began to question the extent to which existing legislation was suffi cient to cover the use of eHealth tools in the provision of healthcare to citizens. Over the past decade, a number of articles, reports, and studies have established that the use of ICTs in healthcare does raise a number of legal questions, but few have looked, in detail, at the extent to which European legislation could provide good answers. The Legally eHealth Report, therefore, seeks to examine some keys of the legal questions raised by the adoption of eHealth tools in healthcare. It looks at how EU legislation on data protection, product and services liability, and trade and competition law applies. |
|||
Survey: Do European Residents Use the Internet To Find Health Information? From the "Norwegian Centre for Telemedicine"
In Eastern Europe, 47% of survey respondents in Latvia and 53% of survey respondents in Poland reported using the Internet in 2007 for health information research. Meanwhile, in Southern Europe, 32% of survey respondents in Greece and 38% of survey respondents in Portugal reported using the Internet in 2007 for health purposes. |
|||
Health Care Unplugged: The Evolving Role of Wireless Technology Source: iHealth Beat (California Healthcare Foundation magazine) The impact these advances could have on providers, patients, and payers is also explored, as are the difficult issues that must still be resolved. The author concludes that the health care industry's appetite for wireless applications will likely depend more on systemic changes in the way medical services are delivered and reimbursed than the capabilities of the technology itself. The complete report is available under Document Downloads below. Document Downloads: |
|||
HHS Report: Health IT, Genetic Medicine To Personalize Care Source: iHealthBeat Today's News (CHCF) The Department of Health and Human Services report offers a long-term plan for creating more customized treatment for patients, including the use of genetic information and health IT. The report predicts that individualized care will create a new doctor-patient relationship. HHS also said personalized care cannot be realized without interoperable, electronic systems. (Healthcare IT News et al) (read the full announcement....) |
|||
Legal eHEALTH Challenges Source: ICT for eHealth http://www.ehealthnews.eu/content/view/618/62/ There are a number of examples in the health area on which Member States cannot act alone effectively and where cooperative action at the EU level is indispensable, especially regarding issues with a cross-border dimension or relating to the free movement of persons within the internal EU market. Both existing and emerging disparities in Member States' legislation and case-law concerning healthcare impair the development of cross-border services and produce distortions of competition. Differences exist across Member States on the local, regional and national level in terms of per capita spending on and inputs to healthcare systems. Member States try their best to improve those systems as well as they can. Lack of financial resources is not the only problem. Quality, accessibility and sustainability of care are also limited because best practices are not shared. In line with the eHealth Action Plan the Commission will issue a Recommendation on eHealth interoperability in 2007, addressing the core eHealth infrastructure data (patient summary, emergency data set). It is expected that the ongoing Commission's Health Services Initiative will equally cover cross-border healthcare services which move electronically. Download "Legal Challenges in eHealth - eHealth facilitates access to Europe-wide healthcare" [ ICT for Health Unit (eHealth) Publication (.pdf, 1,1 MB) ] |
|||
Report on the State of Developing Electronic Patient Summaries in European Union Member States and Beyond Source: ehealthnews.eu The Report analyses the current state of developing electronic patient summaries in European Union Member States and beyond. It highlights the benefits of such summaries and also the difficulties that need to be overcome to make use of patient summaries in different countries. Patient Summaries are a key component for eHealth roadmaps in several countries. The concept of a Patient Summary is not yet universal and fixed, and thus the features of the summaries largely depend on the eHealth programme in which they are embedded. The overall scenarios for deployment of Patient Summaries depend on strategic decisions in each national and regional jurisdiction, which influence the format and the usage of clinical documents. Besides Patient Summaries, most eHealth programmes also involve various kinds of clinical documents in electronic formats, such as prescriptions and diagnostic reports. A precondition for the success of patient summaries is the deployment of suitable infrastructures to identify citizens and professionals, to make available repositories and registries for the management of clinical documents across healthcare facilities, and to apply confidentiality measures. All results will consecutively be made available at the eHealth ERA website (www.ehealth-era.org). The report is the outcome of research in the context of eHealth ERA, which is implemented by empirica GmbH (co-ordinating partner, Germany), STAKES (Finland), CITTRU (Poland), ISC III (Spain), CNR (Italy) and EPSRC (United Kingdom), based on a Coordination Action contract with the European Commission. Read the eHealth ERA Report at : |
|||
Bringing new IT skills to the NHS Source: "eHealthInsider - Education" (http://ehieurope.com) The NHS is implementing new computer systems at an unprecedented rate. Some support is available from system suppliers but the NHS must ensure that the systems are fully supported on an on-going basis. More NHS staff than ever before are required to have technical skills which they can apply to computer systems used for the provision of healthcare. These health informatics staff are becoming as vital to the NHS as their clinical and administrative colleagues. By providing up to date, accurate clinical information about the condition and treatment of a patient, better care can be provided and outcomes improved. (read more....) |
(Report) Health Information Technology: Are Long Term Care Providers Ready? Source: iHealthtBeat (CHCF) This Report explores the readiness for Health Information Technology (HIT) from the perspective of California's long term care providers: nursing facilities, residential care facilities, and community-based service providers. Four questions are examined to better understand provider readiness or level of preparedness for HIT:
The findings show that the realities of the long term care environment must be taken into account in planning and that they must be addressed during implementation if HIT adoption and use are to be a success. Several next steps are put forth to address identified barriers, make HIT a priority, and increase provider perception of HIT benefits over costs. The complete Report is available under Document Downloads below. |
|
IT Tools for Chronic Disease Management: How Do They Measure Up? Chronic disease management systems (CDMS) focus specifically on managing chronic disease and preventive care, while the more comprehensive electronic medical record (EMR) documents the entire patient encounter and provides real-time patient information. Few, if any, studies, have compared the merits of these two tools, which show potential to reduce costs and improve outcomes for patients with chronic illnesses. “IT Tools for Chronic Disease Management: How Do They Measure Up?” assesses them side by side. (read more....) |
|
|
Half of Outsourced IT Projects Will Fail In 2003, half of all information technology projects involving third-party consulting will be considered unsuccessful by executives who oversee them, according to a new report from Gartner, because they fail to deliver expected return on investment or operational value. (more) |
|
|
|
|
The Problems with Secure E-Mail
|
|
| |
Copyright 1998-2011© EHTO All rights reserved This server is the only official EHTO WWW knowledge repository. Mail suggestions to: webmaster@ehto.org |